Massmedica S.A. (WSE:MSM)

Massmedica Income Statement

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	32.61	26.36	24.83	21.61	18.19
Revenue Growth (YoY)	23.72%	6.18%	14.89%	18.78%	-3.01%
Cost of Revenue	20.13	16.6	15.27	12.86	10.96
Gross Profit	12.48	9.76	9.56	8.75	7.23
Selling, General & Admin	8.51	7.02	6.8	6.87	5.53
Other Operating Expenses	2.1	1.37	1.28	0.85	0.49
Operating Expenses	11.16	8.86	8.67	8.1	6.4
Operating Income	1.33	0.9	0.88	0.65	0.83
Interest Expense	-0.41	-0.02	-0.02	-0.04	-0.05
Interest & Investment Income	-	0.03	0.02	-	-
Currency Exchange Gain (Loss)	-	-0.02	-0.02	-	-
Other Non Operating Income (Expenses)	-0.05	-0.38	-0.28	-0.08	0.01
EBT Excluding Unusual Items	0.86	0.5	0.58	0.53	0.79
Gain (Loss) on Sale of Assets	-	-0	-0	-0.04	-0.01
Pretax Income	0.86	0.5	0.58	0.5	0.78
Income Tax Expense	0.24	0.19	0.17	0.15	0.18
Net Income	0.63	0.31	0.41	0.35	0.6
Net Income to Common	0.63	0.31	0.41	0.35	0.6
Net Income Growth	100.78%	-24.19%	17.83%	-42.06%	41.18%
Shares Outstanding (Basic)	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2
EPS (Basic)	0.26	0.13	0.17	0.14	0.25
EPS (Diluted)	0.26	0.13	0.17	0.14	0.25
EPS Growth	100.78%	-24.19%	17.83%	-42.06%	41.18%
Free Cash Flow	-0.13	-0.57	0.07	-1.69	1.18
Free Cash Flow Per Share	-0.05	-0.23	0.03	-0.70	0.49
Gross Margin	38.28%	37.02%	38.50%	40.49%	39.73%
Operating Margin	4.07%	3.40%	3.56%	3.01%	4.57%
Profit Margin	1.92%	1.18%	1.66%	1.62%	3.31%
Free Cash Flow Margin	-0.39%	-2.15%	0.29%	-7.82%	6.48%
EBITDA	1.87	1.38	1.47	1.03	1.21
EBITDA Margin	5.72%	5.22%	5.94%	4.77%	6.66%
D&A For EBITDA	0.54	0.48	0.59	0.38	0.38
EBIT	1.33	0.9	0.88	0.65	0.83
EBIT Margin	4.07%	3.40%	3.56%	3.01%	4.57%
Effective Tax Rate	27.50%	37.44%	29.20%	29.57%	22.55%
Revenue as Reported	32.61	26.36	24.83	21.61	18.19

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.